Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas

Adv Oncol. 2024 May;4(1):101-110. doi: 10.1016/j.yao.2024.02.003. Epub 2024 Feb 23.
No abstract available

Keywords: ClpP agonism; diffuse midline gliomas; dopamine receptor; dopamine receptor antagonism; gliomas; imipridones.